Hypothesis: sarcoidosis is a STAT1-mediated disease
James T Rosenbaum1, Sirichai Pasadhika, Elliott D Crouser
1Casey Eye Institute, Oregon Health & Science University, Portland, OR 97239, USA. rosenbaj@ohsu.edu
Clinical Immunology (Orlando, Fla.)
|May 26, 2009
Summary
Patients with sarcoidosis show distinct mRNA profiles, particularly involving interferon and STAT1 pathways. This finding suggests STAT1 plays a key role in sarcoidosis immunopathogenesis.
Area of Science:
- Immunology
- Genomics
- Molecular Biology
Background:
- The immunologic pathways driving sarcoidosis pathogenesis remain largely undefined.
- Understanding these pathways is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate characteristic messenger RNA (mRNA) profiles in patients with sarcoidosis.
- To identify key molecular pathways and potential therapeutic targets in sarcoidosis.
Main Methods:
- Gene expression analysis using microarrays on peripheral blood, lung, and lymph node samples from sarcoidosis patients and healthy controls.
- Quantitative analysis of transcriptomic data, including fold change and statistical significance (q value).
Main Results:
- Significant upregulation and downregulation of numerous transcripts were observed in peripheral blood of sarcoidosis patients compared to controls.
- Elevated expression of interferon-associated transcripts and STAT1 was detected in peripheral blood, lung, and lymph node samples.
- Granulomas in sarcoidosis lymph nodes showed abundant STAT1 and phosphorylated STAT1, indicating pathway activation.
Conclusions:
- STAT1 (Signal Transducer and Activator of Transcription 1) is strongly implicated in the pathogenesis of sarcoidosis.
- The findings provide a novel hypothesis linking interferon signaling, T helper 1 (TH1) cell predominance, and sarcoidosis, potentially unifying disparate clinical observations.
Related Concept Videos
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...